Drug Database
NI

nicotinic acid (nicotinic acid ER / Niaspanor / Niaspan)

✓ Approved

Merck KGaA · HCAR2 · Small Molecule

What is nicotinic acid?

nicotinic acid is a small molecule developed by Merck KGaA. It is approved for therapeutic indications via oral (po).

Drug Profile

Brand Namesnicotinic acid ER, Niaspanor, Niaspan
CompanyMerck KGaA
Drug ClassSmall Molecule
Molecular TargetHCAR2
RouteOral (PO)
StatusApproved

Mechanism of Action

Molecular Targets

nicotinic acid acts on 1 molecular target:

HCAR2hydroxycarboxylic acid receptor 2 (NIACR1, GPR109A)
Want deeper analysis?Noah AI can explain complex mechanisms and compare to similar drugs.

Therapeutic Indications

nicotinic acid is developed for 8 unique indications across 4 therapeutic areas.

Therapeutic AreaConditionPhase
Vascular disordersArteriosclerosis✓ Approved
Metabolism and nutrition disordersHypercholesterolaemia✓ Approved
Metabolism and nutrition disordersHypertriglyceridaemia✓ Approved
Cardiac disordersMyocardial infarction✓ Approved
Metabolism and nutrition disordersDyslipidaemia✓ Approved

+3 more indications available with a free account

Sign up free to view all indications →

Related Research Articles

PubMedNatural product reports2026-10-15

γ-Amino acid-containing natural products of bacterial origin: structure, biosynthesis, and bioactivity.

Götze Sebastian S, Decker Tanya T, Balluff Sven S, Beemelmanns Christine C

Covering: 1966 to 2026γ-Amino acids are structurally diverse non-proteinogenic building blocks that endow bacterial natural products with unique conformational, physicochemical, and biological properties. Although individual γ-amino acid-containing metabolites have been extensively investigated, their structural diversity, biosynthetic origins, and functional significance have rarely been considered from a unified perspective. Here, we review nearly six decades of research on bacterial γ-amino acid-containing natural products, covering from 1966 and the discovery of bleomycin to genome-guided discoveries in 2026. We discuss the major structural classes of γ-amino acids, including GABA-derived, β-keto, statine-type, vinylogous, fully reduced, and masked amino acid-derived motifs, and highlight how these building blocks are generated through primary metabolism, hybrid NRPS-PKS assembly lines, and specialized tailoring reactions. Particular emphasis is placed on the relationships between γ-amino acid structure, biosynthetic logic, and biological function, including their roles in protease inhibition, covalent target engagement, metallophore activity, and microbial ecology. Finally, we discuss emerging opportunities for genome mining and biosynthetic engineering that are expected to accelerate the discovery and exploitation of γ-amino acid-containing natural products.

PubMedAnimal bioscience2026-10-15

Nutritional and metabolic mechanisms linking low protein and low amino acid diets to fatty liver in laying hens.

Murai Atsushi A, Yamazaki Misae M, Furukawa Kyohei K

Fatty liver is a common metabolic disorder in laying hens and is strongly influenced by dietary protein and amino acid supply. Low protein or low amino acid diets disrupt the balance between nitrogen and energy intake, enhancing hepatic de novo lipogenesis. Severe dietary protein and amino acid deficiency also impairs hepatic apolipoprotein synthesis and secretion. These metabolic alterations promote hepatic triglyceride accumulation and increase susceptibility to fatty liver. Although nutrient-sensing mechanisms in birds remain incompletely defined, evidence from mammalian studies suggests that amino acid deficiency may activate GCN2-ATF4 signaling and modulate mTORC1 activity, contributing to lipogenic reprogramming. Importantly, protein dilution alone rarely induces severe steatosis; rather, the combination of low protein and excessive dietary energy (HELP diet feeding) markedly amplifies lipogenesis, oxidative stress, inflammation, and hepatic injury, accelerating progression toward fatty liver hemorrhagic syndrome (FLHS). This review summarizes current knowledge on the physiological and molecular mechanisms linking low protein and low amino acid diets to fatty liver in laying hens, evaluates the HELP model as an experimental framework for FLHS, and outlines nutritional and functional additives shown to mitigate HELP-induced hepatic pathology. Together, these insights provide a mechanistic basis for developing safer low protein feeding strategies in modern layer production.

PubMedFrontiers in physiology2026-10-15

Ceramidase is involved in metabolic reprogramming of fibroblasts under hypoxia conditions.

Terlizzi Michela M, D'Andria Emmanuel E, Colarusso Chiara C, Di Caprio Simone S et al.

Physiological metabolic reprogramming is a cells strategy to resist/counteract stress to preserve homeostasis. Hypoxia is an important stress stimulus that can promote tissue remodeling and fibrosis, in which alterations in sphingolipid metabolism may contribute to fibroblast responses. Here, we investigated the potential role of acid ceramidase (ASAH1), a key enzyme of the sphingolipid salvage pathway, in fibroblast adaptation to hypoxic stress. Human fibroblasts were exposed to hypoxia for 24, 48, and 72 hours, and metabolic and redox changes were investigated following pharmacological inhibition of acid ceramidase with D-Nmappd. These findings were complemented by analyses of publicly available bulk and single-cell RNA sequencing datasets from idiopathic pulmonary fibrosis (IPF) lungs. Hypoxic fibroblasts showed metabolic remodeling involving glucose-, amino acid-, and redox-associated pathways, together with changes consistent with an adaptive antioxidant response, including alterations in the GSH/GSSG balance. Pharmacological inhibition of acid ceramidase under hypoxia was associated with changes in carnitine metabolism and long-chain fatty acid β-oxidation, reduced GSH and GSSG levels, and decreased expression of Nuclear Factor Erythroid 2-Related Factor 2 (NRF2), Superoxide dismutase 2 (SOD2), and 8-Oxoguanine DNA Glycosylase 1 (OGG1). In IPF lung tissue, ASAH1 expression was associated with glycolytic and redox-related genes. Single-cell analysis showed that ASAH1-expressing IPF fibroblasts were enriched in transcriptional programs related to hypoxic responses and oxidative stress regulation and displayed features associated with a less activated phenotype. Overall, these findings suggest that acid ceramidase/ASAH1 is associated with fibroblast metabolic and redox adaptation to hypoxic stress and may influence fibroblast activation in IPF.

PubMedNature communications2026-10-15

Early coconut oil exposure suppresses chronic experimental Crohn's disease via myristic acid and enhanced regulatory T cells.

Rodriguez-Palacios Alex A, Raffner Basson Abigail A, Menghini Paola P, Ezeji Jessica J et al.

Public health advisory guidelines caution against the consumption of saturated fats, especially coconut oil (CO), yet CO is widely consumed in regions with low inflammatory bowel disease prevalence (IBD) and is often perceived as beneficial by IBD patients. CO is rich in medium-chain saturated fatty acids, notably lauric acid (C12:0) and myristic acid (C14:0) which are negligible in mammalian tissues without dietary intake. Because IBD is linked to saturated fats consumption, here we tested and unexpectedly found that CO and its saturated fatty acids are beneficial suppressing intestinal inflammation in SAMP1/YitFc mice, a chronic IBD model of Crohn's disease-like ileitis. In young mice, the early exposure to a high-dose CO-based diet prevented ileitis in 63.64% of animals (95%CI = 30.79-to-89.07%). Importantly, comparable protection was observed at lower doses amenable for human translation. Although CO did not reverse established disease in adult mice, when combined with steroids, it prolonged the period of steroid-induced remission illustrating its therapeutic benefits in IBD. Disease prevention was associated with myristic acid and correlated with anti-inflammatory microbiota shifts and enhanced regulatory T-cell responses, without adverse effects. Findings challenge current dietary advisories against CO and support reevaluation of CO and myristic acid as anti-inflammatory dietary adjuvants for the prevention and management of established IBD.

PubMedFrontiers in pharmacology2026-10-15

Chicoric acid-rich extract of Cichorium intybus seeds (CAREOCI) preserves pancreatic β-cell function under glucotoxic stress through modulation of MAFA, DYRK1A, cell cycle, apoptosis, and mitochondrial dysfunction.

Khan Anish Murtaja Alam AMA, Chandra Kailash K, Choudhary Furqan F, Alam Aftab A et al.

Progressive decline in functional pancreatic β-cell mass is a key pathological feature of type 2 diabetes mellitus (T2DM), highlighting the need for therapies that preserve and regenerate β-cells. This study investigated the preservative effects of a chicoric acid-rich aqueous extract of Cichorium intybus seeds (CAREOCI) under glucotoxic conditions (25 mM glucose) in pancreatic β-cells. Phytochemical standardisation by HPTLC, HPLC, and LC-MS/MS confirmed chicoric acid is the principal constituent present in CAREOCI. A molecular docking study identified DYRK1A is a one of the key target (-8.72 kcal/mol) of chicoric acid for β-cell regeneration. In glucotoxic MIN 6 β-cells, CAREOCI significantly enhanced glucose-stimulated insulin secretion, restored antioxidant status, reduced intracellular ROS, and suppressed IL-1β and TNF-α. CAREOCI also reduced apoptosis, attenuated caspase-3/7 activity, preserved normal nuclear morphology, restored mitochondrial membrane potential, and promoted autophagy through increased acidic vesicular organelles. Cell-cycle analysis indicated a trend toward increased S-phase population, suggesting enhanced β-cell proliferation. At the molecular level, CAREOCI downregulated DYRK1A, NF-κB, mTOR, and CHOP while upregulating MAFA, PDX1, PAX6, and NKX6.1, supporting β-cell survival and preservation. Compared with purified chicoric acid, CAREOCI consistently exhibited greater efficacy, indicating potential complementarity among its phytoconstituents. CAREOCI protects pancreatic β-cells through coordinated antioxidant, anti-inflammatory, anti-apoptotic, mitochondrial-protective, autophagy-promoting effects, supporting beta cell preservation and function under glucotoxicity condition supporting its potential as a phytopharmaceutical for T2DM.

PubMedAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026-10-15

Toward Rational Design of Aqueous Battery Membranes Beyond the Selectivity-Conductivity Trade-Off.

Liu Jinkang J, Xie Mingbo M, Wang Zhenghao Z, Li Huacun H et al.

Electrochemical energy-storage systems increasingly require membranes that can simultaneously deliver fast ion transport, suppressed active-species crossover, chemical and dimensional stability, and scalable manufacturability. Yet conventional membrane platforms still struggle to reconcile conductivity with selectivity, while durability and processability remain important practical constraints. Sulfonic-acid-based membranes are particularly attractive because they combine strong acidity, fixed-charge character, and tunable hydrated ionic domains. Together, these features make sulfonic acid groups a versatile design element for regulating transport, exclusion, swelling, and membrane processability. Although these features have been most extensively explored in redox flow batteries, the resulting insights are also highly relevant to the broader design of next-generation energy-storage membranes. This review therefore uses sulfonic-acid-based membranes in redox flow batteries as a representative platform to extract transferable design principles. It covers proton-transport mechanisms, synthetic and microstructural design strategies, representative fluorinated and non-fluorinated membrane classes with flexible and rigid architectures, and their roles in vanadium, zinc, and emerging organic redox flow batteries. It further discusses cost, durability, dimensional stability, scale-up, and future opportunities in localized sulfonic-acid placement, biomass-derived membranes, and data-driven design. By clarifying structure-transport-manufacturing relationships, this review extracts general design principles for advanced membranes across electrochemical energy-storage systems.

+9996 more articles available with a free account

Sign up free to view all articles →

Ask about nicotinic acid